文献速递急性肾损伤慢性肾脏病

尸检肾活检发现与SARS-CoV-2(COVID-19)患者急性肾损伤的关联

Association between Postmortem Kidney Biopsy Findings and Acute Kidney Injury from Patients with SARS-CoV-2 (COVID-19).
PubMed 文献 · Clin J Am Soc Nephrol · 2021-03-29

这项多中心观察性研究对墨西哥城85例COVID-19死亡患者行尸检肾活检(光镜和电镜),分析组织病理特征与临床变量(包括AKI严重程度)的关联。结果显示慢性合并症高发,49%存在2-3级急性肾小管损伤,色素管型与肾功能未恢复显著相关。

要点

  • COVID-19死亡患者肾活检中慢性病变高发:动脉硬化81%、FSGS 29%、糖尿病肾病27%。
  • 色素管型与严重AKI后肾功能未恢复显著相关(OR 0.07,95%CI 0.01-0.77)。
  • 组织病理特征与严重AKI无显著关联,但炎症标志物和药物使用与特定病理发现相关。

核心结论

  • COVID-19死亡患者肾活检中慢性合并症高发,色素管型与严重AKI后肾功能未恢复独立相关。

研究设计与样本

  • 多中心观察性研究,纳入墨西哥城三家三级中心85例COVID-19死亡患者,行尸检肾活检光镜和电镜分析。

主要发现

  • 中位年龄57(49-66)岁,69%男性,BMI 29(26-35)kg/m2,51%有糖尿病史,46%有高血压史。
  • 98%接受抗凝治疗,66%使用类固醇,35%接受至少一种潜在肾毒性药物,54%存在严重AKI。
  • 活检显示FSGS 29%、糖尿病肾病27%、动脉硬化81%,2-3级急性肾小管损伤49%。
  • 色素管型与肾功能恢复概率显著降低相关(OR 0.07,95%CI 0.01-0.77)。

关键数值与推荐

  • 严重AKI定义为符合研究标准,占54%;急性肾小管损伤分级2-3级占49%。
  • 色素管型与肾功能未恢复的OR为0.07(95%CI 0.01-0.77)。

临床怎么用

  • COVID-19死亡患者肾活检常见慢性病变,色素管型提示AKI后肾功能恢复可能性低。
  • 氨基糖苷类/多粘菌素、CRP、白蛋白、ACEI/ARB、抗病毒药、NSAIDs和抗凝药与特定病理发现相关。

局限性

  • 仅纳入死亡患者,存在选择偏倚;样本量85例,为观察性研究,不能推断因果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: AKI in coronavirus disease 2019 (COVID-19) is associated with higher morbidity and mortality. The objective of this study was to identify the kidney histopathologic characteristics of deceased patients with diagnosis of COVID-19 and evaluate the association between biopsy findings and clinical variables, including AKI severity. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Our multicenter, observational study of deceased patients with COVID-19 in three third-level centers in Mexico City evaluated postmortem kidney biopsy by light and electron microscopy analysis in all cases. Descriptive and association statistics were performed between the clinical and histologic variables. RESULTS: A total of 85 patients were included. Median age was 57 (49-66) years, 69% were men, body mass index was 29 (26-35) kg/m2, 51% had history of diabetes, 46% had history of hypertension, 98% received anticoagulation, 66% were on steroids, and 35% received at least one potential nephrotoxic medication. Severe AKI was present in 54% of patients. Biopsy findings included FSGS in 29%, diabetic nephropathy in 27%, and arteriosclerosis in 81%. Acute tubular injury grades 2-3 were observed in 49%. Histopathologic characteristics were not associated with severe AKI; however, pigment casts on the biopsy were associated with significantly lower probability of kidney function recovery (odds ratio, 0.07; 95% confidence interval, 0.01 to 0.77). The use of aminoglycosides/colistin, levels of C-reactive protein and serum albumin, previous use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, antivirals, nonsteroid anti-inflammatory drugs, and anticoagulants were associated with specific histopathologic findings. CONCLUSIONS: A high prevalence of chronic comorbidities was found on kidney biopsies. Nonrecovery from severe AKI was associated with the presence of pigmented casts. Inflammatory markers and medications were associated with specific histopathologic findings in patients dying from COVID-19.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Rivero J, Merino-López M, Olmedo R, et al. Association between Postmortem Kidney Biopsy Findings and Acute Kidney Injury from Patients with SARS-CoV-2 (COVID-19). Clin J Am Soc Nephrol. 2021. PMID: 33782033. doi:10.2215/CJN.16281020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。